Experience

• 

  Ranbaxy

  Feb 2004 - Sept 2008

  Formulation development of Novel Drug Delivery systems, Technology transfer to plant, Execution of Exhibit Batches, Preparing CMC documents required for filing in US and Europe, Responses to queries from regulatory agencies for filed products. Formulation development of ANDAs (Controlled Release). Literature survey, Review of patents, defining non-infringing strategies for ANDAs. Handled Para IV ANDAs. Also new projects for Domestic market. Formulation development of controlled release formulation based on immediate release data (PK, Drug release). Formulation development for ANDAs (Controlled Release). Dosage forms comprising of Pellets in capsules, Matrix Tablets, Coated tablets.

  • Senior research scientist

    Feb 2008 - Sept 2008

  • Research Scientist

    Feb 2006 - Jan 2008

  • Research Associate

    Feb 2004 - Jan 2006
• 

  Piramal pharmaceutical development services pvt ltd

  Sept 2008 - Mar 2012

  Group leader

  Dealing in formulation development, process development of NCE molecules for Phase I, II and III studies, generic Immediate release and modified release dosage forms for Multi National Clients. Involved in proposal preparation for the project, discussion with client on the proposal, project initiation, execution and completion within a stipulated timeframe. Formulation development comprising of API in Capsule, API in Bottle, Powder in Capsule, Powder in Bottle, immediate release and modified release Tablets etc for Initial phases of Clinic. Using material sparing approaches for early development where API is very limited. Over-encapsulation strategies for blinding of formulation and comparator dosage forms. Show less

• 

  Piramal group

  Apr 2012 - Sept 2014

  Senior group leader- formulation development

  * Formulation Development for NDAs, ANDAs, 505(b)2s, all kind of solid oral dosage forms * Process Development and Optimization using QbD based approach* Managing Projects from inception to completion * Guiding Team of enthusiastic, talented and creative scientists* Managing cGMP aspects of Pilot Plant

• 

  Merck gruppe

  Apr 2017 - Dec 2018

  Innovation around Consumer Health BrandsDevelopment and management of projects comprising of Tablets, Capsules (Hard and Soft Gelatin), Liquids, creams, Nasal formulations

  • Research Development Lead

    Sept 2014 - Dec 2018

  • Head, MAPLab, Consumer Health R&D

    Apr 2017 - Nov 2018
• 

  Procter & gamble

  Dec 2018 - now

  • Director, AMA PHC R&D

    Apr 2024 - now

  • Head MAPLab, P&G Health

    Dec 2018 - Apr 2024
• 

  Procter & gamble

  -

  Director, ama phc r&d